Abstract
These recommendations for quality improvement of cystic fibrosis genetic diagnostic testing provide general guidelines for the molecular genetic testing of cystic fibrosis in patients/individuals. General strategies for testing as well as guidelines for laboratory procedures, internal and external quality assurance, and for reporting the results, including the requirements of minimal services in mutation testing, the nomenclature for describing mutations, procedures to control false-positive amplification reactions and to validate tests, and guidelines to implement a quality system in a molecular diagnostic laboratory are reviewed.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dequeker, E., Cuppens, H., Dodge, J. et al. Recommendations for quality improvement in genetic testing for cystic fibrosis European Concerted Action on Cystic Fibrosis. Eur J Hum Genet 8 (Suppl 2), S2–S12 (2000). https://doi.org/10.1038/sj.ejhg.5200487
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ejhg.5200487
Keywords
This article is cited by
-
Molecular Basis of Cystic Fibrosis Disease: An Indian Perspective
Indian Journal of Clinical Biochemistry (2010)
-
Variability in the use of CE-marked assays for in vitro diagnostics of CFTR gene mutations in European genetic testing laboratories
European Journal of Human Genetics (2009)
-
Genetische Grundlagen der andrologischen Subfertilität
Gynäkologische Endokrinologie (2007)
-
Screening of mutations in the CFTR gene in 1195 couples entering assisted reproduction technique programs
European Journal of Human Genetics (2005)
-
Optical detection and discrimination of cystic fibrosis-related genetic mutations using oligonucleotide–nanoparticle conjugates
Analytical and Bioanalytical Chemistry (2005)